{
}
Deutsche Bank AG increased its stake in The Clorox Company by 14% in Q4, owning 654,198 shares valued at $106.2 million. Clorox reported a quarterly EPS of $1.45, missing estimates, with revenue down 8% year-over-year. The company also declared a quarterly dividend of $1.22, yielding 3.62%.
Hedge funds and institutional investors hold 78.53% of Clorox's stock, which has recently faced a series of downgrades from analysts, with Barclays cutting its target price to $129.00. The company reported a quarterly EPS of $1.45, missing estimates, and revenue declined by 8% year-over-year. Analysts maintain a consensus rating of "Hold" with a target price of $152.38.
Deutsche Bank has lowered its price target for Clorox to $150 from $166 while maintaining a hold rating. Clorox, a leader in consumer products, generates 53% of its net sales from home maintenance and laundry products, 27.5% from household items, and 16.4% from international activities, with the U.S. accounting for 83.6% of total sales.
Barclays has adjusted its price target for Clorox Company to $139 from $140. Clorox is a leading producer of consumer products, with net sales primarily from home maintenance and laundry products (53%), followed by household products (27.5%) and other categories (3.1%). The U.S. market represents 83.6% of its net sales.
BNP Paribas Exane has revised its price target for Clorox to $141 from $146 while maintaining an underperform rating. Clorox, a leader in consumer products, generates 53% of its net sales from home maintenance and laundry products, with significant contributions from household products (27.5%) and other categories (3.1%). The U.S. market represents 83.6% of its total sales.
The consumer healthcare market is projected to grow significantly, reaching $1,476.45 billion by 2028, with a CAGR of 22.1%. Key drivers include an aging population, increased reliance on OTC medications, and the rise of e-commerce. Major players like Johnson & Johnson and Sanofi are adapting to trends in digital health and personalized care solutions.
Clorox CEO Linda Rendle detailed the company's recovery from a significant cyberattack that disrupted production and led to a loss of market share. The company has since restored distribution and regained most of its market share through investments in advertising and innovation. While the cat litter brand Fresh Step faced challenges, it is rebounding, and Rendle indicated potential future acquisitions as the deal market begins to heat up.
The collagen supplement market, valued at $1.8 billion in 2022, is projected to grow at a CAGR of 8.2% through 2030, driven by rising health awareness and beauty trends. Pills and gummies dominated the market, while pharmacies emerged as the leading distribution channel. North America leads in demand, fueled by an aging population and a focus on natural wellness solutions.
Clorox Co. has raised its annual profit guidance to as much as $6.90 per share, up from a previous forecast of $6.80, following a boost in advertising that helped the company regain market share lost due to a cyberattack last year. Analysts had estimated earnings of $6.65. The company maintained its guidance for revenue and organic sales.
The Clorox Company
Companies
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
clorox reports quarterly revenue decline and announces dividend payment
12:02 13.05.2025
clorox faces analyst downgrades and mixed investor sentiment in market
15:17 09.05.2025
deutsche bank lowers clorox price target while maintaining hold rating
13:14 22.04.2025
barclays lowers clorox company price target to 139 from 140
12:47 26.03.2025
bnp paribas exane lowers clorox price target maintains underperform rating
11:04 25.03.2025
consumer healthcare market poised for rapid growth driven by digital innovations
United States Dollar
Perrigo Company plc
Cardinal Health, Inc.
Johnson & Johnson
Church & Dwight Co., Inc.
Herbalife Nutrition Ltd.
Nestlé S.A.
Abbott Laboratories
Teva Pharmaceutical Industries Ltd.
AstraZeneca PLC
DSM Nutritional Products AG
Pfizer Inc.
Colgate-Palmolive Company
AbbVie Inc.
Bayer AG
BASF SE
Glaxosmithkline plc
Novartis International AG
CVS Health Corporation
Boehringer Ingelheim International GmbH
Sanofi
Amway Corporation
Novo Nordisk A/S
Ipsen S.A.
Bristol-Myers Squibb Company
McKesson Corporation
Merck & Co., Inc.
The Clorox Company
Reckitt Benckiser Group plc
Cigna Corporation
Eli Lilly and Company
Brian Johnson
Show more
00:30 27.11.2024
Clorox CEO outlines recovery strategy following significant cyberattack disruption
00:25 01.11.2024
collagen supplement market poised for significant growth through 2030
United States Dollar
The Clorox Company
Shiseido Company, Limited
USA
Nature's Bounty
BioTech USA Kft.
Optimum Nutrition
Renew Life Formulas
Shiseido Company
Show more
12:17 31.10.2024
clorox raises profit outlook as advertising boosts sales and market share
21:10 30.10.2024
Trending
Subcategory
Countries:
Companies:
Currencies:
People: